Inari Medical, founded with the mission to transform the lives of patients suffering from venous diseases, is a commercial-stage medical device company. The company focuses on developing innovative products designed to treat conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari Medical aims to provide effective, minimally invasive solutions that improve patient outcomes and quality of life. Their market focus is primarily in the United States, with plans to expand their product availability and regulatory compliance to other regions including EMEA, APAC, and Latin America/Canada.

Notable affiliated individuals include key medical professionals and industry experts who contribute to the company's innovative approach. Inari Medical has received significant investment from venture capital firms that specialize in healthcare technologies. Key achievements include the successful commercialization of their flagship products and positive clinical outcomes reported by healthcare providers. The overall impact of Inari Medical is reflected in its commitment to advancing medical treatments for venous diseases, thereby improving patient care and setting new standards in the medical device industry.